Circumferential evaluation of the neointima by optical coherence tomography after ABSORB bioresorbable vascular scaffold implantation: Can the scaffold cap the plaque?
- 3 January 2012
- journal article
- research article
- Published by Elsevier BV in Atherosclerosis
- Vol. 221 (1), 106-112
- https://doi.org/10.1016/j.atherosclerosis.2011.12.008
Abstract
No abstract availableKeywords
Funding Information
- Abbott Vascular, Santa Clara, California, USA
This publication has 26 references indexed in Scilit:
- Evaluation of the Second Generation of a Bioresorbable Everolimus-Eluting Vascular Scaffold for the Treatment of De Novo Coronary Artery Stenosis: 12-Month Clinical and Imaging OutcomesJournal of the American College of Cardiology, 2011
- Evaluation of the Second Generation of a Bioresorbable Everolimus Drug-Eluting Vascular Scaffold for Treatment of De Novo Coronary Artery StenosisCirculation, 2010
- Intracoronary Optical Coherence Tomography and Histology at 1 Month and 2, 3, and 4 Years After Implantation of Everolimus-Eluting Bioresorbable Vascular Scaffolds in a Porcine Coronary Artery ModelCirculation, 2010
- Coronary Stents: Looking ForwardJournal of the American College of Cardiology, 2010
- Coronary Stents: Current StatusJournal of the American College of Cardiology, 2010
- First case of stenting of a vulnerable plaque in the SECRITT I trial—the dawn of a new era?Nature Reviews Cardiology, 2009
- A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methodsThe Lancet, 2009
- A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trialThe Lancet, 2008
- Pathological Correlates of Late Drug-Eluting Stent ThrombosisCirculation, 2007
- Pathology of Drug-Eluting Stents in HumansJournal of the American College of Cardiology, 2006